161 related articles for article (PubMed ID: 36346787)
1. Risk association of RANKL and OPG gene polymorphism with breast cancer to bone metastasis in Pashtun population of Khyber Pakhtunkhwa, Pakistan.
Hayat F; Khan NU; Khan AU; Ahmad I; Alamri AM; Iftikhar B
PLoS One; 2022; 17(11):e0276813. PubMed ID: 36346787
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphism of the OPG gene associated with breast cancer.
Ney JT; Juhasz-Boess I; Gruenhage F; Graeber S; Bohle RM; Pfreundschuh M; Solomayer EF; Assmann G
BMC Cancer; 2013 Jan; 13():40. PubMed ID: 23369128
[TBL] [Abstract][Full Text] [Related]
3. The association between RANKL and Osteoprotegerin gene polymorphisms with breast cancer.
Omar HS; Shaker OG; Nassar YH; Marzouk SA; ElMarzouky MS
Mol Cell Biochem; 2015 May; 403(1-2):219-29. PubMed ID: 25724681
[TBL] [Abstract][Full Text] [Related]
4. Association of OPG and RANKL gene polymorphisms with bone mineral density in Indian women.
Nair S; Bhadricha H; Patil A; Surve S; Joshi B; Balasinor N; Desai M
Gene; 2022 Oct; 840():146746. PubMed ID: 35868414
[TBL] [Abstract][Full Text] [Related]
5. RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus.
Bonfá AC; Seguro LP; Caparbo V; Bonfá E; Pereira RM
Osteoporos Int; 2015 May; 26(5):1563-71. PubMed ID: 25609157
[TBL] [Abstract][Full Text] [Related]
6. Association of SNP-SNP Interactions Between RANKL, OPG, CHI3L1, and VDR Genes With Breast Cancer Risk in Egyptian Women.
Shaker OG; Senousy MA
Clin Breast Cancer; 2019 Feb; 19(1):e220-e238. PubMed ID: 30309792
[TBL] [Abstract][Full Text] [Related]
7. Significant association of BRCA1 (rs1799950), BRCA2 (rs144848) and TP53 (rs1042522) polymorphism with breast cancer risk in Pashtun population of Khyber Pakhtunkhwa, Pakistan.
Khan Y; Khan NU; Ali I; Khan S; Khan AU; Iqbal A; Adams BD
Mol Biol Rep; 2023 Jul; 50(7):6087-6096. PubMed ID: 37300745
[TBL] [Abstract][Full Text] [Related]
8. "Single nucleotide polymorphisms of the OPG/RANKL system genes in primary hyperparathyroidism and their relationship with bone mineral density".
Piedra M; García-Unzueta MT; Berja A; Paule B; Lavín BA; Valero C; Riancho JA; Amado JA
BMC Med Genet; 2011 Dec; 12():168. PubMed ID: 22185226
[TBL] [Abstract][Full Text] [Related]
9. RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients.
Wang J; Lu K; Song Y; Zhao S; Ma W; Xuan Q; Tang D; Zhao H; Liu L; Zhang Q
PLoS One; 2015; 10(7):e0133964. PubMed ID: 26218592
[TBL] [Abstract][Full Text] [Related]
10. Association of
Abdi S; Binbaz RA; Mohammed AK; Ansari MGA; Wani K; Amer OE; Alnaami AM; Aljohani N; Al-Daghri NM
Genes (Basel); 2021 Jan; 12(2):. PubMed ID: 33572979
[TBL] [Abstract][Full Text] [Related]
11. Associations between OPG and RANKL polymorphisms, vertebral fractures, and abdominal aortic calcification in community-dwelling older subjects: the Sao Paulo Ageing & Health Study (SPAH).
Pereira RMR; Figueiredo CP; Cha CC; Caparbo VF; Oliveira RM; Franco AS; Menezes PR; de Castro I; Onuchic LF
Osteoporos Int; 2016 Nov; 27(11):3319-3329. PubMed ID: 27311721
[TBL] [Abstract][Full Text] [Related]
12. The association between RANK, RANKL and OPG gene polymorphisms and the risk of rheumatoid arthritis: a case-controlled study and meta-analysis.
Yang H; Liu W; Zhou X; Rui H; Zhang H; Liu R
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31209146
[TBL] [Abstract][Full Text] [Related]
13. Genetic variations in genes encoding RANK, RANKL, and OPG in rheumatoid arthritis: a case-control study.
Assmann G; Koenig J; Pfreundschuh M; Epplen JT; Kekow J; Roemer K; Wieczorek S
J Rheumatol; 2010 May; 37(5):900-4. PubMed ID: 20231205
[TBL] [Abstract][Full Text] [Related]
14. Single nucleotide polymorphism of RANKL and OPG genes may play a role in bone and joint injury in rheumatoid arthritis.
Xu S; Ma XX; Hu LW; Peng LP; Pan FM; Xu JH
Clin Exp Rheumatol; 2014; 32(5):697-704. PubMed ID: 25068378
[TBL] [Abstract][Full Text] [Related]
15. Expression profile of receptor activator of nuclear-κB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer.
Owen S; Ye L; Sanders AJ; Mason MD; Jiang WG
Anticancer Res; 2013 Jan; 33(1):199-206. PubMed ID: 23267146
[TBL] [Abstract][Full Text] [Related]
16. Bone health in pediatric transfusion-dependent beta-thalassemia: Circulating osteoprotegerin and RANKL system.
Youssry I; Saad N; Madboly M; Samy RM; Hamed ST; Tawfik H; Elbatrawy SR; Kaddah N; Abd Elaziz D
Pediatr Blood Cancer; 2022 Jan; 69(1):e29377. PubMed ID: 34699125
[TBL] [Abstract][Full Text] [Related]
17. Association between osteoprotegerin (OPG), receptor activator of nuclear factor-kappaB (RANK), and RANK ligand (RANKL) gene polymorphisms and circulating OPG, soluble RANKL levels, and bone mineral density in Korean postmenopausal women.
Kim JG; Kim JH; Kim JY; Ku SY; Jee BC; Suh CS; Kim SH; Choi YM
Menopause; 2007; 14(5):913-8. PubMed ID: 17667143
[TBL] [Abstract][Full Text] [Related]
18. Association of Polymorphisms in RANK and RANKL Genes with Osteopenia in Arab Postmenopausal Women.
Abdi S; Bukhari I; Ansari MGA; BinBaz RA; Mohammed AK; Hussain SD; Aljohani N; Al-Daghri NM
Dis Markers; 2020; 2020():1285216. PubMed ID: 33376557
[TBL] [Abstract][Full Text] [Related]
19. Genetic variation in the RANKL/RANK/OPG signaling pathway is associated with bone turnover and bone mineral density in men.
Roshandel D; Holliday KL; Pye SR; Boonen S; Borghs H; Vanderschueren D; Huhtaniemi IT; Adams JE; Ward KA; Bartfai G; Casanueva F; Finn JD; Forti G; Giwercman A; Han TS; Kula K; Lean ME; Pendleton N; Punab M; Silman AJ; Wu FC; Thomson W; O'Neill TW;
J Bone Miner Res; 2010 Aug; 25(8):1830-8. PubMed ID: 20205168
[TBL] [Abstract][Full Text] [Related]
20. RANKL/RANK/OPG Polymorphisms and Heel Quantitative Ultrasound in Young Adults.
Correa-Rodríguez M; Schmidt-RioValle J; Rueda-Medina B
Nurs Res; 2017; 66(2):145-151. PubMed ID: 28252575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
